London Drugs: Important Information for Patients Dependent on ''Allerject'' or ''Allerject Jr.'' Emergency Allergy Anaphylactic Treatment Recalled by Manufacturer Sanofi and Health Canada
(firmenpresse) - RICHMOND, BRITISH COLUMBIA -- (Marketwired) -- 10/29/15 -- All manufactured lots of Allerject and Allerject Jr. emergency anaphylactic allergy reaction treatments were recalled by manufacturer Sanofi and Health Canada on October 28, 2015. There will be thousands of people in Canada who will need to be aware of steps they should take in response to this recall. Below are some answers to questions we anticipate from patients who suffer from severe, life threatening allergies.
It is imperative to note Allerject and Allerject Jr. are often purchased for people needing assistance and children with severe allergies. Reason being, Allerject and Allerject Jr. have vocal functions, allowing children and others to be talked through administering the emergency allergic reaction epinephrine injection. An alternative to Allerject and Allerject Jr. is the Epi-pen.
Important questions answered
What should I do if I have Allerject or Allerject Jr. in the house and at school as the method to treat an emergency allergic reaction?
Do not discard your Allerject or Allerject Jr. until you have a replacement emergency epinephrine treatment such as the Epi-pen. Allerject and Allerject Jr. have been recalled with concerns of functionality but it is better to have this treatment on-hand instead of no treatment, until you have obtained the replacement Epi-pen. If you or someone you know begins to suffer from a severe allergic (anaphylactic reaction) use the Allerject or Allerject Jr. and call 911 immediately.
Once you have been able to replace your Allerject and Allerject Jr. with an Epi-pen, return Allerject and Allerject Jr. to the pharmacy for proper disposal.
London Drugs is calling all patients on record with Allerject and Allerject Jr. prescriptions to advise of the recall. Patients should be in contact with their local London Drugs pharmacist to obtain replacement treatment. There will be significant numbers of people needing to replace their Allerject and Allerject Jr. emergency treatments. London Drugs is working diligently to secure as much Epi-pen stock as possible, as soon as possible, for our patients and our customers. Prescriptions are not required to replace emergency epinephrine treatment.
The Health Canada recall can be found here:
If you have any questions please call your local London Drugs pharmacy or London Drugs customer service at 1-888-991-2299.
Contacts:
Wendy Hartley
604-817-2758
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.10.2015 - 08:54 Uhr
Sprache: Deutsch
News-ID 1395460
Anzahl Zeichen: 2077
contact information:
Contact person:
Town:
RICHMOND, BRITISH COLUMBIA
Phone:
Kategorie:
Drugs
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 329 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"London Drugs: Important Information for Patients Dependent on ''Allerject'' or ''Allerject Jr.'' Emergency Allergy Anaphylactic Treatment Recalled by Manufacturer Sanofi and Health Canada
"
steht unter der journalistisch-redaktionellen Verantwortung von
London Drugs Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
